Pathologic stage of ypT0N+ rectal cancers following neo-adjuvant treatment: clinical interpretation of an orphan status
Laura Lorenzon(Agostino Gemelli University Polyclinic), Stefano Mancini, Michele De Simone, Daniela Rega(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Alberto Biondi(Agostino Gemelli University Polyclinic), Leonardo Vincenti, Andrea Sagnotta(Ospedale San Filippo Neri), Marta Sandin(University of Siena), Gaetano Gallo(Magna Graecia University), Mario Trompetto, Alfredo Mellano(Candiolo Cancer Institute), Raffaele De Luca(Istituto Tumori Bari), Graziella Marino(Centro di Riferimento Oncologico della Basilicata), Genoveffa Balducci, Andrea Muratore(Candiolo Cancer Institute), Dario Parini(Ospedale Santa Maria della Misericordia di Rovigo), Luigi Marano(Ospedale di Spoleto), Stefano Scabini, Franco Roviello(University of Siena), Gloria Santoro(Agostino Gemelli University Polyclinic), Dario Scala(Centro di Riferimento Oncologico della Basilicata), Vincenzo Vigorita(University Hospital Complex Of Vigo), Patrizia Marsanic(Candiolo Cancer Institute), Raquel Jiménez-Rosellón(Hospital Universitari i Politècnic La Fe), Valeria Andriola, Alessio Lucarini(Sapienza University of Rome), Matteo Frasson, Roberto Persiani(Istituto Tumori Bari), Alejandro Ruano Poblador(Ospedale di Spoleto), Giampaolo Montesi, Luca Turati(Azienda Ospedaliera Treviglio), Giovanni Sgroi, Giuseppe La Torre, Alessandra Aprile(Ospedale Policlinico San Martino), Domenico D’Ugo(University of Ioannina), Paolo Delrio, Alberto Patriti
Cited by 3
Related Papers
Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation
|Nature Medicine|2019|1.1k
Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus
|Annals of Oncology|2020|313
Healthy Lifestyle and Cancer Risk: Modifiable Risk Factors to Prevent Cancer
|Nutrients|2024|212
Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets
|International Journal of Molecular Sciences|2022|190